APC resistance and other haemostatic variables during pregnancy and puerperium

Thrombosis and Haemostasis

Volumn 81, Issue 4, 1999, Pages 527-531

  Kjellberg, U ^a   Andersson, N E ^b   Rosen S ^b   Tengborn, L ^a   Hellgren, M ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Chromogenix AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 8; D DIMER; FIBRIN; FIBRINOGEN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEIN C; PROTEIN S; PROTHROMBIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; REFERENCE VALUE;

EID: 0032957708     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614518     Document Type: Article

References (33)

1. Department of Health and Social Security Report 1991 on Confidential Enquiries into Maternal Deaths in England and Wales 1985-87, HMSO, London.
2. Franks AL, Atrash HK, Lawson HW, Colberg KS. Obstetrical pulmonary embolism mortality. United States 1970-85. Am J Public Health 1990; 80: 720-2.
3. Högberg U. Maternal mortality in Sweden. Thesis, Umeå, Sweden. 1985: 118.
4. Greer IA. Hemostasis and thrombosis in pregnancy. In: Hemostasis and Thrombosis. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, eds. Edingburgh: Churchill Livingstone 1978: 987-8.
5. Lindoff C, Lecander I, Åstedt B. Fibrinolytic components in individual consecutive plasma samples during normal pregnancy. Fibrinolysis 1993; 7: 190-4.
6. Lecander I, Åstedt B. Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma. Br J Haematol 1986; 62: 221-8.
7. Hellgren M, Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol 1995; 173:210-3.
8. Zöller B, Svensson PJ, He X, Dahlbäck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosisprone families with inherited resistance to activated protein C J Clin Invest 1994; 94: 2521-4.
9. Zöller B, Hillarp A, Berntorp E, Dahlbäck B. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis. Annu. Rev Med 1997; 48: 45-58.
10. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (Activated protein C resistance). Blood 1995; 85: 1504-8.
11. Vasse M, Leduc O, Borg J-Y, Chrétien MH, Monconduit M. Resistance to activated protein C: Evaluation of three functional assays. Thromb Res 1994; 76: 47-59.
12. Cumming AM, Tait RC, Fildes S, Yoong A, Keeney S, Hay CRM. Development of resistance to activated protein C during pregnancy. Br J Haematol 1995; 90: 725-7.
13. Mathonnet F, Mazancourt P de, Bastenaire B, Morot M, Benattar N, Beufé S, Borg J-Y,Giudicelli Y. Activated protein C sensitivity ratio in pregnant women at delivery. Br J Haematol 1996; 92: 244-6.
14. Schlit A-F, Col-de Beys C, Moriau M, Lavenne-Pardonge E. Acquired activated protein C resistance in pregnancy. Thromb Res 1996; 84: 203-6.
15. Peek MJ, Nelson-Piercy C, Manning RA, Swiet M de, Letsky EA. Activated protein C resistance in normal pregnancy. Br J Obstet Gynaecol 1997; 104: 1084-6.
16. Gumming AM, Tail RC, Fildes S, Hay CRM. Diagnosis of APC resistence during pregnancy. Br J Haematol 1996; 92: 1026-7.
17. Hathaway WE, Bonnar J. Hemostayic disorders of pregnant woman and newborn infant. New York: Elsevier 1987: 42-5.
18. Stirling Y, Woolf L, North WRS, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost 1984; 52 (2): 176-82.
19. Faught W, Garner P, Jones G, Ivey B. Changes in protein C and protein S levels in normal pregnancy. Am J Obstet Gynecol 1995; 172: 147-50.
20. Bremme K, Östlund E, Almqvist I, Heinonen K, Blombäck M. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynecol 1992; 80: 132-7.
21. Ginsberg JS, Siragusa S, Douketis J, Johnston M, Moffat K, Stevens P, Brill-Edvards P, Panju A, Patel A. Evaluation of a soluble fibrin assay in patients with suspected deep vein thrombosis. Thromb Haemost 1995; 74: 833-6.
22. Bremme K, Lind H, Blombäck M. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy. Obstet Gynecol 1993: 81:78-83.
23. Comeglio P, Fedi S, Liotta AA, Cellai AP, Chiarantini E, Prisco D, Mecatti F, Parretti E, Mello G, Abbate R. Blood clotting activation during normal pregnancy. Thromb Res 1996; 84: 199-202.
24. Ishii A, Yamada S, Yamada R, Hamada H. t-PA activity in peripheral blood obtained from pregnant women. J Perinat Med 1994; 22: 113-7.
25. Estellés A, Gilabert J, Andrés C, España F, Aznar J. Plasminogen activator inhibitors type 1 and type 2 and plasminogen activators in amniotic fluid during pregnancy. Thromb Haemost 1990; 64: 281-5.
26. Sörensen JD, Secher NJ, Jespersen J. Perturbed (progoagulant) endothelium and deviations within the fibrinolytic system during the third trimester of normal pregnancy. Acta Obstet Gynecol Scand 1995; 74: 257-61.
27. Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and preeclampsia. Br J Obstet Gynaecol 1994; 101:488-92.
28. Nolan TE, Smith RP, Devoe LD. Maternal plasma D-dimer levels in normal and complicated pregnancies. Obstet Gynecol 1993; 81: 235-8.
29. Francalanci I, Comeglio P, Liotta AA, Cellai AP, Fedi S, Parretti E, Mello G, Prisco D, Abbate R. D-dimer concentrations during normal pregnancy, as measured by Elisa. Thromb Res 1995; 78: 399-405.
30. Koh SCL, Chew CYC, Viegas OAC, Choo M, Ratnam SS. Influence of circulating D-dimer levels on assays of fibrinogen. Ann Acad Med Singapore 1994; 23: 856-60.
31. Ronde H de, Bertina RM. Laboratory diagnosis of APC-resistance: A critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994; 72: 880-6.
32. Baker R, Thom J, Barden A, Beilin L, Ritchie J, Graham D, Bocksmeer F van, Walters B, Michael C. Platelet derived microvesicles cause acquired activated protein C resistance in preeclampsia and normal pregnancy. Abstract at XVth Congress of the International Society on Trombosis and Haemostasis, Florence, Italy 1997. Published in suppliment page 317, June 1997.
33. Walker MC, Garner PR, Keely FJ, Rock GA, Reis MD. Changes in activated protein C resistance during normal pregnancy. Am J Obstet Gynecol 1997; 177: 162-9.